Cargando…
Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk
Type 2 diabetes mellitus (DM) represents, with its macro and microvascular complications, one of the most critical healthcare issues for the next decades. Remarkably, in the context of regulatory approval trials, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor...
Autores principales: | d’Aiello, Alessia, Bonanni, Alice, Vinci, Ramona, Pedicino, Daniela, Severino, Anna, De Vita, Antonio, Filomia, Simone, Brecciaroli, Mattia, Liuzzo, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217924/ https://www.ncbi.nlm.nih.gov/pubmed/37239990 http://dx.doi.org/10.3390/ijms24108643 |
Ejemplares similares
-
Targeting Collagen Pathways as an HFpEF Therapeutic Strategy
por: Bonanni, Alice, et al.
Publicado: (2023) -
Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation
por: Vinci, Ramona, et al.
Publicado: (2021) -
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture
por: Vinci, Ramona, et al.
Publicado: (2022) -
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge
por: Bonanni, Alice, et al.
Publicado: (2022) -
Editorial: Artificial intelligence applied to coronary artery diseases: from pathophysiology to precision medicine
por: Vinci, Ramona, et al.
Publicado: (2023)